OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Cancer Survivors on How Immunotherapy Saved Their Lives and the Critical Need for Research Funding

25 Posts Not To Miss from MASCC 2026

FDA Approves Sacituzumab Govitecan Plus Pembrolizumab for First-Line PD-L1–Positive TNBC

Radiotherapy in Sudan: Cancer Care Under Pressure From Infrastructure Gaps and Armed Conflict

Discussions Around Retraction of Debated Study on Early Morning Immunotherapy Benefits

Oncology News, Insights, Stories by OncoDaily

Daraxonrasib
Voices

“Maybe the Best Thing That Happened Is That Didn’t Work Out”: Alan Sandler on Daraxonrasib

Julie Gralow
Voices

Key Insights from ASCO Breakthrough 2026 with Julie Gralow

Napoleon Bonaparte cause of death
Celebrities and Cancer

What Really Killed Napoleon? The Autopsy Evidence Behind His Gastric Cancer Diagnosis

Dr. Melvin L.K. Chua Receives MedNews Week Excellence in Mentorship Award at ASCO Breakthrough 2026

DUTRENEO Study: Spatial Architecture Explains Biomarker Failure in Neoadjuvant Bladder Cancer Immunotherapy

Discussions Around Retraction of Debated Study on Early Morning Immunotherapy Benefits

Jeremy Clarkson’s Prostate Cancer Story: Early Detection, Treatment, and Remission

European Commission Approves Trodelvy for First-Line Metastatic TNBC in Patients Ineligible for PD-(L)1 Inhibitors

FDA Launches Operation TrialBlazer to Accelerate and Modernize Clinical Development 2026

20 Posts Not To Miss From ESMOGynae26

Voices
Mina Sedrak, Mina S. Sedrak

Mina Sedrak: Why Protected Time Remains One of the Greatest Challenges Facing Clinical Trialists

Mathew George: AI as a Clinical Teaching Co-Pilot

Naoto T Ueno: Best of ASCO Panel Explores Cancer Patient Diversity and Health Disparities

Tom Powles: A New Nectin-4 MMAE Peptide with Unique Potential

Roupen Odabashian: FDA Just Cleared Something We've Been Talking About Hypothetically for Two Years

Paolo Tarantino: DAPHNe Study Explores Reducing Chemotherapy Without Compromising Outcomes

Paolo Tarantino: On My Way Back From JBCS26, Reflecting on the Closing Plenary Session

FDA Approvals
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz (pivekimab sunirine-pvzy), the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

European School of Oncology's Master in Sarcoma

European School of Oncology

25 Sep
sarcoma

ESO-EONS Masterclass in Oncology Nursing 2026

European School of Oncology

06 Nov
Oncology Nursing

European School of Oncology's Refresher Course on Melanoma

European School of Oncology

16 Sep
European School of Oncology (ESO)

Momentum 2026: Accelerating Europe’s Action On Cancer

Cancerfonden – The Swedish Cancer Society

14 Oct
Momentum

VIDAWASI International Medical Congress 2026

VIDAWASI PERÚ

20 Oct
VIDAWASI

Immune-oncology
ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

FDA Approves Sacituzumab Govitecan Plus Pembrolizumab for First-Line PD-L1–Positive TNBC

New Biomarkers for Immunotherapy Success in Metastatic Kidney Cancer

HYPERPROG Study: Hyperprogressive Disease After Immune Checkpoint Inhibitors

GT-20 Trial: Personalized Neoantigen Vaccines for Glioblastoma

Atezolizumab Plus Bevacizumab in Child-Pugh B Hepatocellular Carcinoma

OCEANUS Study: Combination of Radiotherapy and Immunotherapy in Advanced NSCLC

Gastrointestinal-Oncology
FORTITUDE

Insights From FORTITUDE-101 and FORTITUDE-102: FGFR2b Overexpression in Advanced Gastric and GEJ Cancer

PRODIGE 81-TRIPLET-HCC: Ipilimumab Added to Atezolizumab and Bevacizumab in Advanced HCC

Daraxonrasib at ASCO 2026: The Pancreatic Cancer Moment That Brought the Room to Its Feet

10 Must-Read Posts In GI Oncology This Week

PancreaSure 5-Biomarker Panel for Early and Advanced PDAC Detection

ASCO 2026 Highlights by GI Cancers Alliance: What’s New in Stomach Cancer Care

Practice-Changing and Promising Trials in GI Oncology From ASCO 2026

Breast-Oncology
T-Bren

T-Bren Shows Early Activity Across HER2-Positive and HER2-Low Advanced Breast Cancer

Can Breast-Conserving Surgery Be Oncologically Safe for Multiple Ipsilateral Breast Cancers?

10 Essential Breast Oncology Posts You Can’t Miss This Week

Can 12 Weeks of THP Be Enough for Some Patients With Early HER2-Positive Breast Cancer?

FDA Approves Palbociclib-Based Maintenance Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer

European Commission Approves Trodelvy for First-Line Metastatic TNBC in Patients Ineligible for PD-(L)1 Inhibitors

SACI-IO HR+ Trial: 5 Promising Findings in Metastatic Breast Cancer

Lung-Oncology
Nivolumab Plus Ipilimumab

Who May Be at Risk of Early Detriment With First-Line Nivolumab Plus Ipilimumab in Metastatic NSCLC?

When ADC Toxicity Is Not the Same for Everyone: A Sex-Based Signal in NSCLC

Nature Medicine Retracts NSCLC Immunochemotherapy Trial: 6 Serious Concerns Explained

Can a Routine CT Scan Predict PD-L1 Expression in Metastatic NSCLC?

TROP2 Targeting May Delay EGFR-TKI Resistance in EGFR-Mutant NSCLC

Amivantamab Shows Preclinical Immune-Mediated Activity in Mesothelioma Through Dual EGFR and MET Targeting

Maintenance Pemetrexed May Not Improve Survival With Pembrolizumab in Advanced Nonsquamous NSCLC

OncoDaily TV
Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Kefah Mokbel

Kefah Mokbel: Can Diet Influence Cancer Risk and Outcomes?

Empowering Oncologists: How to make the most of your fellowship?

Empowering Oncologists: How to make the most of your fellowship?

STAMP Inhibitors Against CML: Prof. Timothy Hughes

STAMP Inhibitors Against CML: Prof. Timothy Hughes

Oncology's Greatest Threat: A System in Crisis

Oncology’s Greatest Threat: A System in Crisis

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Annalice Gandini

GI News Updates with Annalice Gandini

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Not To Miss
FDA

Oncology Community Welcomes Two New FDA Approvals for Breast Cancer

15 Posts Not To Miss From ASCO Breakthrough 2026

25 Posts Not To Miss from MASCC 2026

EORTC Announces 2027 Summit for Clinical Cancer Research in Brussels

20 Posts Not To Miss From ESMOGynae26

15 Posts Not To Miss From ESCardioOnco26

Top Growing Medical Universities in Latin America: 2026 Edition by BIGR

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
DLBCL NHL

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): Evolving Biology and Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

CancerWorld

Oncologists
Nataliya Kovalchuk

Nataliya Kovalchuk

Oncologists Location Stanford, USA
Joyce Kambugu

Joyce Kambugu

Oncologists Location Kampala, Uganda
Jean-Yves Blay

Jean-Yves Blay

Oncologists Location Lyon, France
Javier David Benítez

Javier David Benítez

Oncologists Location Elche, Spain
Abdul Rafeh Naqash

Abdul Rafeh Naqash

Oncologists Location Oklahoma City, USA
Saro Armenian

Saro Armenian

Oncologists Location Duarte, USA
Claudio Cerchione

Claudio Cerchione

Oncologists Location Bologna, Italy
Eric Van Cutsem

Eric Van Cutsem

Oncologists Location Leuven, Belgium

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OncoDaily Medical Journal

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports/Brief Reports

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports